Showing results (1-10 of 208) with videos related to
Sort By:
Pageof 21
Expert Opinion on Investigational Drugs|April 24, 2020
Novel agents for mantle cell lymphoma: molecular rational and clinical dataClémentine Sarkozy, Vincent RibragLeukemia & Lymphoma|September 17, 2009
Exploring mammalian target of rapamycin (mTOR) inhibition for treatment of mantle cell lymphoma and other hematologic malignanciesBertrand Coiffier, Vincent RibragExpert Review of Hematology|March 20, 2023
An evaluation of fedratinib for adult patients with newly diagnosed and previously treated myelofibrosisKhalil Saleh, Vincent RibragBulletin Du Cancer|April 24, 2007
[Non Hodgkin's lymphoma in adolescents]Catherine Patte, Vincent Ribrag, Laurence BrugièresExpert Opinion on Investigational Drugs|November 19, 2015
Investigational drugs for T-cell lymphomaDavid Ghez, Alina Danu, Vincent RibragLa Revue Du Praticien|December 5, 2018
[Burkitt lymphoma, a diagnostic emergency]Swann Bredin, Véronique Vergé, Vincent RibragJournal of Experimental Pharmacology|June 30, 2021
Updates in the Treatment of Peripheral T-Cell LymphomasKhalil Saleh, Jean-Marie Michot, Vincent RibragExpert Review of Hematology|December 23, 2015
Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?Layal El Halabi, David Ghez, Vincent RibragInvestigational New Drugs|October 2, 2015
Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignanciesDiana Markozashvili, Vincent Ribrag, Yegor S VassetzkyExpert Review of Anticancer Therapy|October 27, 2012
Emerging agents for the treatment of mantle cell lymphomaValérie Camara-Clayette, Olivier Hermine, Vincent RibragPageof 21